Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Two Part Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

NCT00209534 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00209534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Two Part Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
February 29, 2004
Enrollment
200
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colon polyps, colonoscopy